77 related articles for article (PubMed ID: 1695189)
1. Normal fibronectin levels after surgical treatment of portal hypertension in liver cirrhosis.
De Angelis V; Zambon M; Toffolo L; Voltan GP; Orazi BM; Santarossa L; Donada C; Zuin R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):89-93. PubMed ID: 1695189
[TBL] [Abstract][Full Text] [Related]
2. Low fibronectin in portal hypertension.
Foster PN; Bowen M; Howdle PD; Losowsky MS
Digestion; 1983; 28(2):122-4. PubMed ID: 6653924
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis.
Delahousse B; Labat-Debelleix V; Decalonne L; d'Alteroche L; Perarnau JM; Gruel Y
Thromb Haemost; 2010 Oct; 104(4):741-9. PubMed ID: 20806106
[TBL] [Abstract][Full Text] [Related]
4. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
Yin J; Leng X; Zhu J
Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881
[TBL] [Abstract][Full Text] [Related]
5. Soluble P selectin levels in chronic liver disease: relationship to disease severity.
Vardareli E; Saricam T; Demirustu C; Gulbas Z
Hepatogastroenterology; 2007 Mar; 54(74):466-9. PubMed ID: 17523300
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of the cytopenia syndrome in patients with cirrhosis of the liver complicated by portal hypertension].
Eramishantsev AK; Korshunov IB; Belokrinitskiĭ DV; Dudkina LN; Dem'ianov AI
Khirurgiia (Mosk); 1989 Feb; (2):36-9. PubMed ID: 2709711
[TBL] [Abstract][Full Text] [Related]
7. Splenic Doppler impedance indices: influence of different portal hemodynamic conditions.
Bolognesi M; Sacerdoti D; Merkel C; Gerunda G; Maffei-Faccioli A; Angeli P; Jemmolo RM; Bombonato G; Gatta A
Hepatology; 1996 May; 23(5):1035-40. PubMed ID: 8621130
[TBL] [Abstract][Full Text] [Related]
8. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
Rieder H; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
[TBL] [Abstract][Full Text] [Related]
9. Altered basal and postprandial plasma melatonin, gastrin, ghrelin, leptin and insulin in patients with liver cirrhosis and portal hypertension without and with oral administration of melatonin or tryptophan.
Celinski K; Konturek PC; Slomka M; Cichoz-Lach H; Gonciarz M; Bielanski W; Reiter RJ; Konturek SJ
J Pineal Res; 2009 May; 46(4):408-14. PubMed ID: 19552764
[TBL] [Abstract][Full Text] [Related]
10. Effect of spontaneous portal-systemic shunting on plasma insulin and amino acid concentrations.
Iwasaki Y; Sato H; Ohkubo A; Sanjo T; Futagawa S; Sugiura M; Tsuji S
Gastroenterology; 1980 Apr; 78(4):677-83. PubMed ID: 6986317
[TBL] [Abstract][Full Text] [Related]
11. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
Feng H; Zhang Z; Leng X; Li S; Zhu J; Du R
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
[TBL] [Abstract][Full Text] [Related]
12. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
Rios R; Sangro B; Herrero I; Quiroga J; Prieto J
Am J Gastroenterol; 2005 Jun; 100(6):1311-6. PubMed ID: 15929762
[TBL] [Abstract][Full Text] [Related]
13. [Circulation in liver cirrhosis patients and the principles for correcting portal hypertension].
Patsiora MD; Ershov IuA
Khirurgiia (Mosk); 1973 May; 49(5):72-9. PubMed ID: 4795477
[No Abstract] [Full Text] [Related]
14. Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients.
Praticò D; Rossi E; Merli M; Riggio O; FitzGerald GA; Violi F
J Investig Med; 1998 Dec; 46(9):430-4. PubMed ID: 9861778
[TBL] [Abstract][Full Text] [Related]
15. [The incidence of consumption coagulopathy in liver cirrhosis].
Moreno Abadía V; Bermúdez García JM; Maldonado Martín A; Rico Irles J
An Med Interna; 1989 Sep; 6(9):466-71. PubMed ID: 2562720
[TBL] [Abstract][Full Text] [Related]
16. [Products of degradation of fibrinogen in surgical patients].
Golovastova GI; Guseĭnov ChS
Lab Delo; 1975; (6):368-71. PubMed ID: 51128
[No Abstract] [Full Text] [Related]
17. The impact of cirrhosis and portal hypertension on mortality following colorectal surgery: a nationwide, population-based study.
Nguyen GC; Correia AJ; Thuluvath PJ
Dis Colon Rectum; 2009 Aug; 52(8):1367-74. PubMed ID: 19617746
[TBL] [Abstract][Full Text] [Related]
18. [Study of central and porto-hepatic hemodynamics before the surgical treatment of patients with liver cirrhosis and portal hypertension].
Eramishantsev AK; Gogichaĭshvili SSh; Lebezev VM; Kitsenko EA; Dolidze MA
Klin Med (Mosk); 1991 Feb; 69(2):81-3. PubMed ID: 1875671
[TBL] [Abstract][Full Text] [Related]
19. [Blood coagulation disorders in liver cirrhosis in relation to the degree of portal hypertension].
Klingemann HG; Schmidt U; Brunswig D; Egbring R; Kaffarnik H
Fortschr Med; 1980 Oct; 98(40):1561-66. PubMed ID: 6970156
[TBL] [Abstract][Full Text] [Related]
20. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation].
Papp M; Mezei G; Udvardy M; Altorjay I
Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
